Related Experiment Video
Updated: Aug 12, 2026

Purification and Visualization of Lipopolysaccharide from Gram-negative Bacteria by Hot Aqueous-phenol Extraction
Published on: May 28, 2012
Inhibition of polymorphonuclear leucocyte functions in vivo by Yersinia enterocolitica lipopolysaccharide
K T Hartiala1, I Granberg, A Toivanen
1Department of Medical Microbiology, University of Turku, Finland.
Abstract:
A single intravenous injection of 5 micrograms of Yersinia enterocolitica lipopolysaccharide (LPS) inhibits rabbit polymorphonuclear leucocyte (PMN) chemotaxis, enzyme secretion, and respiratory burst activation in response to partially purified rabbit C5a and leucotriene B4 (LTB4). Respiratory burst activation is also inhibited in response to platelet activating factor (PAF). In contrast, all these responses to n-formyl-methionyl-leucyl-phenylalanine (FMLP) remain unaltered. This LPS does not modulate PMN activation in vitro or activate the respiratory burst. Thus Y enterocolitica LPS acts in vivo by inhibiting PMN responses to endogenous mediators of inflammation. This inhibition presumably impairs the elimination of pathogens and might, therefore, provide favourable conditions for induction by bacteria of further immunological consequences.
Insights
Yersinia enterocolitica lipopolysaccharide (LPS) administered intravenously inhibits rabbit polymorphonuclear leucocyte (PMN) responses to inflammatory mediators. This immune suppression may hinder pathogen clearance and promote further bacterial infections.
Area of Science:
- Immunology
- Microbiology
- Cell Biology
Background:
- Lipopolysaccharides (LPS) from Gram-negative bacteria are potent immune modulators.
- Polymorphonuclear leucocytes (PMNs) are critical for innate immunity and pathogen clearance.
- Understanding LPS effects on PMN function is vital for host defense mechanisms.
Purpose of the Study:
- To investigate the in vivo effects of Yersinia enterocolitica LPS on rabbit PMN functions.
- To determine if Y. enterocolitica LPS modulates PMN responses to specific inflammatory mediators.
Main Methods:
- Rabbits received a single intravenous injection of Y. enterocolitica LPS.
- PMN chemotaxis, enzyme secretion, and respiratory burst activation were assessed.
- Responses to C5a, leukotriene B4 (LTB4), and n-formyl-methionyl-leucyl-phenylalanine (FMLP) were evaluated.
Main Results:
- Y. enterocolitica LPS significantly inhibited PMN chemotaxis, enzyme secretion, and respiratory burst.
- Inhibition was observed for responses to C5a, LTB4, and platelet-activating factor (PAF).
- PMN responses to FMLP remained unaffected, and LPS did not activate PMNs in vitro.
Conclusions:
- Y. enterocolitica LPS exerts an in vivo inhibitory effect on rabbit PMN functions.
- This LPS impairs PMN responses to endogenous inflammatory mediators.
- The observed inhibition may compromise pathogen elimination and facilitate secondary bacterial infections.
More Related Videos
Related Concept Videos
Formation of Lipopolysaccharides
Plague
Inhibitors of Gram-positive Cell Wall Synthesis

